Carregant...
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the Alzheimer’s disease (AD) continuum. Investigating populations with SCD is important for understanding the early pathological mechanisms of AD and identifying SCD-related biomarkers, which are critical for the e...
Guardat en:
| Publicat a: | Mol Neurodegener |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507636/ https://ncbi.nlm.nih.gov/pubmed/32962744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-020-00395-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|